Invion Limited (ASX:IVX)
Australia · Delayed Price · Currency is AUD 0.0790
+0.0010 (1.28%)
Mar 4, 2026, 3:47 PM AEST
Invion Market Cap
Invion has a market cap or net worth of 6.68 million as of March 4, 2026. Its market cap has decreased by -40.65% in one year.
Market Cap
6.68M
Enterprise Value
7.41M
Revenue
-1.07K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since February 15, 2010, Invion's market cap has decreased from 23.91M to 6.68M, a decrease of -72.06%. That is a compound annual growth rate of -7.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 6.68M | -16.13% |
| Dec 30, 2025 | 7.97M | -58.93% |
| Dec 31, 2024 | 19.39M | -39.60% |
| Dec 29, 2023 | 32.11M | -44.43% |
| Dec 30, 2022 | 57.78M | -57.12% |
| Dec 31, 2021 | 134.75M | 143.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Little Green Pharma | 33.64M |
| Vitura Health | 30.49M |
| IDT Australia | 21.37M |
| Peak Processing | 19.70M |
| Cann Group | 11.12M |
| Epsilon Healthcare | 9.73M |
| ECS Botanics Holdings | 9.58M |
| Percheron Therapeutics | 7.61M |